ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
9,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
10,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
11,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
12,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
13,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
14,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
17,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
19,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
19,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
20,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
21,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
22,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
23,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
23,2,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
24,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
26,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
28,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
29,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
29,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
30,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
31,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
34,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
35,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
35,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
36,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
39,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
40,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
43,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
44,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
45,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
48,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
49,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
49,3,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
50,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,2,Headache,Headaches NEC,Headaches,Nerv,N
54,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
56,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
57,1,Headache,Headaches NEC,Headaches,Nerv,N
58,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
59,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
59,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
60,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
60,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
60,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
60,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
60,5,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
60,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
60,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
60,8,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
60,9,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
60,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
60,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
60,12,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
60,13,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
61,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
61,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
62,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Penile dermatitis,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
66,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
67,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
67,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
69,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
72,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
73,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
74,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
77,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
78,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
79,1,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
80,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
82,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
83,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
83,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
84,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
85,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
86,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
87,1,Autonomic dysreflexia,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
87,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
88,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Autonomic dysreflexia,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
89,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
89,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
90,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
90,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
91,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
93,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
94,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
94,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
96,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
97,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
98,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
100,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
101,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
102,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
103,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
104,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
105,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
105,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
105,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
105,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
105,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
106,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
107,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
108,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
109,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
110,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
113,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
116,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
118,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
119,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
120,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
123,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
123,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
126,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
126,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
127,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
127,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
127,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
128,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
133,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
135,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
136,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
137,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,1,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
139,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
140,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
141,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
141,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
141,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
141,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
141,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
142,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
143,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
145,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
146,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
146,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
147,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
147,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
147,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
147,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
150,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
151,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
152,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
153,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
154,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
155,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
156,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
156,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
158,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
160,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
161,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
162,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
163,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
165,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
166,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
166,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
167,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
169,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
170,1,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
170,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
170,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
170,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
170,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
171,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
